Coronavirus infection in chemosensory cells
- PMID: 36719595
- PMCID: PMC9888344
- DOI: 10.1007/s13365-023-01117-3
Coronavirus infection in chemosensory cells
Abstract
Clinical manifestations of human coronavirus (HCoV)-related diseases are mostly related to the respiratory system, although secondary complications such as headache, anosmia, ageusia, and myalgia have been reported. HCoV infection and replication in chemosensory cells associated with ageusia and anosmia is poorly understood. Here, we characterized HCoV-OC43 and SARS-CoV-2 infection in two types of chemosensory cells, olfactory and taste cells, with their unique molecular and histological characteristics. We first assessed HCoV-OC43 infection in in vitro cultured human olfactory epithelial cells (hOECs) and fungiform taste papilla (HBO) cells. Interestingly, while both cell types were susceptible to HCoV-OC43 infection, viral replication rates were significantly reduced in HBO cells compared to hOECs. More interestingly, while culture media from hOECs was able to produce secondary infection in Vero cells, there was very limited secondary infection from HBO cells, suggesting that HBO cells may not be able to release infectious virus. On the other hand, unlike HCoV-OC43, SARS-CoV-2 showed comparable levels of viral infection rates in both hOECs and HBO cells. Furthermore, our RT-qPCR-based gene array studies revealed that several key genes involved in taste and olfactory functions were significantly altered by SARS-CoV-2 infection. These results may suggest a possible mechanism associated with chemosensory symptoms, such as anosmia and ageusia in patients infected with SARS-CoV-2.
Keywords: Chemosensory; Coronavirus; HCoV-OC43; Olfactory cells; SARS-CoV-2; Taste cells.
© 2023. The Author(s) under exclusive licence to The Journal of NeuroVirology, Inc.
Figures




Similar articles
-
Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.J Med Virol. 2022 Apr;94(4):1450-1456. doi: 10.1002/jmv.27460. Epub 2021 Nov 24. J Med Virol. 2022. PMID: 34786736 Free PMC article.
-
Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2.J Virol Methods. 2022 Jan;299:114317. doi: 10.1016/j.jviromet.2021.114317. Epub 2021 Oct 9. J Virol Methods. 2022. PMID: 34634321 Free PMC article.
-
Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.J Virol. 2021 May 24;95(12):e00490-21. doi: 10.1128/JVI.00490-21. Print 2021 May 24. J Virol. 2021. PMID: 33789998 Free PMC article.
-
Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19.Viruses. 2023 Feb 20;15(2):578. doi: 10.3390/v15020578. Viruses. 2023. PMID: 36851792 Free PMC article. Review.
-
An overview on the seven pathogenic human coronaviruses.Rev Med Virol. 2022 Mar;32(2):e2282. doi: 10.1002/rmv.2282. Epub 2021 Aug 2. Rev Med Virol. 2022. PMID: 34339073 Review.
Cited by
-
Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects.Int J Mol Sci. 2024 Aug 5;25(15):8527. doi: 10.3390/ijms25158527. Int J Mol Sci. 2024. PMID: 39126095 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous